NasdaqCM - Delayed Quote • USD
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 6:34 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 72.61k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MORAN SEAN F Chief Financial Officer | Conversion of Exercise of derivative security at price 30.00 per share. | Direct | 53,610 | Apr 10, 2024 |
| CORMORANT ASSET MANAGEMENT ,L.P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 37.82 - 45.96 per share. | Indirect | 23,327,560 | Mar 8, 2024 |
| SMETHURST DOMINIC Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 27, 2024 |
| MORAN SEAN F Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| COHEN YUVAL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| CORMORANT ASSET MANAGEMENT ,L.P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 26.72 per share. | Indirect | 20,040,000 | Feb 2, 2024 |
| HOLMER ALAN F Director | Conversion of Exercise of derivative security at price 4.97 per share. | Direct | 3,126 | Jan 26, 2024 |
| COHEN YUVAL Chief Executive Officer | Conversion of Exercise of derivative security at price 4.97 per share. | Direct | 35,680 | Jan 26, 2024 |
| CORMORANT ASSET MANAGEMENT ,L.P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 25.73 - 34.62 per share. | Indirect | 8,412,311 | Jan 26, 2024 |
| MORAN SEAN F Chief Financial Officer | Purchase at price 0.26 per share. | Direct | 5,198 | Aug 10, 2022 |
| COHEN YUVAL Chief Executive Officer | Purchase at price 0.26 per share. | Direct | 1,003 | Aug 10, 2022 |
| MILLIAN CRAIG STUART Chief Operating Officer | Purchase at price 0.25 per share. | Direct | 1,272 | Aug 10, 2022 |
| MORAN SEAN F Chief Financial Officer | Purchase at price 0.30 per share. | Direct | 3,600 | May 16, 2022 |
| COHEN YUVAL Chief Executive Officer | Purchase at price 0.25 per share. | Direct | 2,625 | May 16, 2022 |
| MORAN SEAN F Chief Financial Officer | Purchase at price 0.37 per share. | Direct | 5,550 | Mar 10, 2022 |
| MILLIAN CRAIG STUART Chief Operating Officer | Purchase at price 0.37 per share. | Direct | 3,700 | Mar 10, 2022 |
| COHEN YUVAL Chief Executive Officer | Purchase at price 0.37 per share. | Direct | 3,182 | Mar 9, 2022 |
| MORAN SEAN F Chief Financial Officer | Sale at price 1.40 - 1.75 per share. | Direct | 228,179 | Dec 21, 2020 |
| MORAN SEAN F Chief Financial Officer | Conversion of Exercise of derivative security at price 1.00 - 1.40 per share. | Direct | 176,110 | Dec 21, 2020 |
| MORAN SEAN F Chief Financial Officer | Sale at price 1.32 per share. | Direct | 48,628 | Dec 16, 2020 |
| MORAN SEAN F Chief Financial Officer | Conversion of Exercise of derivative security at price 0.17 per share. | Direct | 6,118 | Dec 16, 2020 |
| COHEN YUVAL Chief Executive Officer | Purchase at price 1.21 per share. | Direct | 5,126 | Nov 11, 2020 |
| WHITE BARBARA Officer | Purchase at price 3.63 per share. | Direct | 56,650 | Mar 17, 2020 |
| COHEN YUVAL Chief Executive Officer | Purchase at price 3.49 per share. | Direct | 15,007 | Mar 17, 2020 |
| MILLIAN CRAIG STUART Officer | Purchase at price 4.25 per share. | Direct | 8,500 | Mar 17, 2020 |
| DISCORDIA ROBERT PAUL Chief Operating Officer | Purchase at price 3.54 per share. | Direct | 10,054 | Mar 17, 2020 |
| WHITE BARBARA Officer | Purchase at price 4.38 per share. | Direct | 14,992 | Nov 12, 2019 |
| COHEN YUVAL Chief Executive Officer | Purchase at price 4.26 per share. | Direct | 6,092 | Nov 12, 2019 |
| MILLIAN CRAIG STUART Officer | Purchase at price 4.38 per share. | Direct | 4,380 | Nov 11, 2019 |
| DISCORDIA ROBERT PAUL Chief Operating Officer | Purchase at price 4.62 per share. | Direct | 11,558 | Nov 11, 2019 |
| MILLIAN CRAIG STUART Officer | Purchase at price 5.48 per share. | Direct | 8,213 | Aug 15, 2019 |
| WHITE BARBARA Officer | Purchase at price 6.10 per share. | Direct | 9,998 | Aug 12, 2019 |
| COHEN YUVAL Chief Executive Officer | Purchase at price 6.06 per share. | Direct | 7,116 | Aug 12, 2019 |
| MILLIAN CRAIG STUART Officer | Purchase at price 6.00 per share. | Direct | 9,000 | Aug 12, 2019 |
| DISCORDIA ROBERT PAUL Chief Operating Officer | Purchase at price 5.86 per share. | Direct | 87,894 | Aug 12, 2019 |
| WHITE BARBARA Officer | Purchase at price 7.20 per share. | Direct | 10,001 | May 17, 2019 |
| MORAN SEAN F Chief Financial Officer | Purchase at price 7.12 per share. | Direct | 712 | May 14, 2019 |
| MILLIAN CRAIG STUART Officer | Purchase at price 7.23 per share. | Direct | 7,227 | May 14, 2019 |
| COHEN YUVAL Chief Executive Officer | Purchase at price 6.99 per share. | Direct | 6,955 | May 13, 2019 |
| HOCHMAN DAVID P Director | Purchase at price 6.98 per share. | Indirect | 13,958 | Mar 15, 2019 |
| JENKINS JOHN KENNETH M.D. Director | Purchase at price 6.98 per share. | Direct | 6,978 | Mar 15, 2019 |
| MORAN SEAN F Chief Financial Officer | Purchase at price 6.67 per share. | Direct | 10,005 | Mar 14, 2019 |
| WHITE BARBARA Officer | Purchase at price 6.47 per share. | Direct | 29,994 | Mar 14, 2019 |
| COHEN YUVAL Chief Executive Officer | Purchase at price 6.49 per share. | Direct | 9,930 | Mar 14, 2019 |
| MILLIAN CRAIG STUART Officer | Purchase at price 6.85 per share. | Direct | 34,258 | Mar 14, 2019 |
| TEPPER MARK A President | Conversion of Exercise of derivative security at price 1.00 per share. | Direct | 10,000 | Nov 14, 2018 |
| HOCHMAN DAVID P Director | -- | Indirect | -- | May 24, 2018 |
| MORAN SEAN F Chief Financial Officer | Purchase at price 5.77 per share. | Direct | 23,080 | May 15, 2018 |
| WHITE BARBARA Officer | Purchase at price 5.87 per share. | Direct | 15,174 | May 15, 2018 |
| COHEN YUVAL Chief Executive Officer | Purchase at price 5.85 per share. | Direct | 10,091 | May 15, 2018 |
Related Tickers
JANX Janux Therapeutics, Inc.
47.39
+0.62%
ELEV Elevation Oncology, Inc.
3.6200
-0.69%
VINC Vincerx Pharma, Inc.
0.7300
-18.59%
CGEM Cullinan Therapeutics, Inc.
25.30
+31.43%
APM Aptorum Group Limited
5.28
-3.65%
CADL Candel Therapeutics, Inc.
6.39
-0.62%
DAWN Day One Biopharmaceuticals, Inc.
14.92
+12.94%
ANVS Annovis Bio, Inc.
18.01
+32.43%
ADCT ADC Therapeutics SA
4.3400
-2.25%
OCUL Ocular Therapeutix, Inc.
4.7450
+12.98%